ENDPOINTS NEWS22h
Sci­en­tists and star­tups re­veal new gene in­ser­tion tech­niques, though much re­mains be­hind closed doors: #AS­GCT24
Several secretive and well-funded biotechs are sharing the first glimpses of data from a new suite of gene editing tools that ...
ENDPOINTS NEWS17h
New Biose­cure draft fea­tures 2032 grand­fa­ther clause, five-year grace pe­ri­od for added com­pa­nies
Drugmakers would have until 2032 to cut ties with WuXi AppTec and other Chinese life sciences companies, according to an ...
ENDPOINTS NEWS18h
Sen­a­tors ques­tion Cham­ber of Com­merce's mo­tives around march-in rights
Bernie Sanders (I-VT) and Jeff Merkley (D-OR) accused a new US Chamber of Commerce coalition of attempting to “stymie the ...
ENDPOINTS NEWS19h
Blue­bird bio starts 15 pa­tients on its three mul­ti­mil­lion-dol­lar gene ther­a­pies
Bluebird bio’s stock $BLUE jumped over 20% on Thursday following its first-quarter earnings release and the announcement of ...
ENDPOINTS NEWS17h
Gink­go to cut spend­ing, lay off staff af­ter earn­ings dis­ap­point­ment
Gink­go Bioworks is look­ing to cut ex­pens­es and per­son­nel in an ef­fort to re­turn to prof­itabil­i­ty and break even by ...
ENDPOINTS NEWS21h
House Re­pub­li­cans put pres­sure on AS­PR’s man­age­ment of the na­tion­al drug stock­pile
Law­mak­ers in the House En­er­gy and Com­merce Com­mit­tee crit­i­cized the man­age­ment of the na­tion­al stock­pile in a ...